Kronos Bio, Inc. Deferred Tax Assets, Gross
Kronos Bio, Inc. had Deferred Tax Assets, Gross of $141.63 million as of 2024-12-31, per its 10-K filed 2025-03-18.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2025-03-18
- 2024-12-31: Deferred Tax Assets, Gross $141.63M.
- 2023-12-31: Deferred Tax Assets, Gross $126.53M.
- 2022-12-31: Deferred Tax Assets, Gross $107.26M.
- 2021-12-31: Deferred Tax Assets, Gross $66.19M.
| Period end | Deferred Tax Assets, Gross |
|---|---|
| 2024-12-31 | $141.63M 10-K · filed 2025-03-18 |
| 2023-12-31 | $126.53M 10-K · filed 2025-03-18 |
| 2022-12-31 | $107.26M 10-K · filed 2024-03-21 |
| 2021-12-31 | $66.19M 10-K · filed 2023-03-15 |
| 2020-12-31 | $29.19M 10-K · filed 2022-02-24 |
| 2019-12-31 | $6.02M 10-K · filed 2021-03-23 |